Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
10%(1 trials)

Phase Distribution

Ph phase_4
9
60%
Ph not_applicable
1
7%
Ph phase_1
2
13%
Ph phase_2
1
7%
Ph phase_3
1
7%

Phase Distribution

2

Early Stage

1

Mid Stage

10

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
2(14.3%)
Phase 2Efficacy & side effects
1(7.1%)
Phase 3Large-scale testing
1(7.1%)
Phase 4Post-market surveillance
9(64.3%)
N/ANon-phased studies
1(7.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

15

all time

Status Distribution
Active(1)
Completed(10)
Other(4)

Detailed Status

Completed10
unknown3
Suspended1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (14.3%)
Phase 21 (7.1%)
Phase 31 (7.1%)
Phase 49 (64.3%)
N/A1 (7.1%)

Trials by Status

suspended17%
completed1067%
not_yet_recruiting17%
unknown320%

Recent Activity

0 active trials
Showing 5 of 15
not_yet_recruitingphase_4

Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria

NCT07403643
completed

Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya

NCT07362498
completedphase_2

Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy

NCT04661579
suspendedphase_1

Controlled Human Malaria Infection Transmission Model - Phase A

NCT04280692
completedphase_4

Malaria Therapeutic Efficacy Study (TES) Kenya

NCT04767191
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07403643Phase 4

Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria

Not Yet Recruiting
NCT07362498

Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya

Completed
NCT04661579Phase 2

Study of Malaria Vaccine RTS,S/AS01E in Plasmodium Falciparum-infected and Uninfected Adults Pre-treated With Anti-malarial Therapy

Completed
NCT04280692Phase 1

Controlled Human Malaria Infection Transmission Model - Phase A

Suspended
NCT04767191Phase 4

Malaria Therapeutic Efficacy Study (TES) Kenya

Completed
NCT00495508Phase 4

Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During Pregnancy

Completed
NCT02742285Phase 4

Lumefantrine in Venous Plasma Versus Dried Capillary Blood Spot

Completed
NCT02184637Phase 1

A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate

Completed
NCT01976780Phase 4

In Vivo and In Vitro Efficacy of Artemisinin Combination Therapy

Completed
NCT02213211Not Applicable

School-based Programme of Malaria Diagnosis and Treatment in Southern Malawi

Completed
NCT02143934Phase 4

Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity

Completed
NCT01899820Phase 3

Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenya

Unknown
NCT01906788Phase 4

The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy

Unknown
NCT00790881Phase 4

Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults

Completed
NCT01075945Phase 4

Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan

Unknown

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15